{"id":241232,"date":"2026-07-20T17:05:51","date_gmt":"2026-07-20T22:05:51","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2026\/07\/acid-resistant-nanocage-shows-promise-for-targeted-gastric-cancer-therapy"},"modified":"2026-07-20T17:05:51","modified_gmt":"2026-07-20T22:05:51","slug":"acid-resistant-nanocage-shows-promise-for-targeted-gastric-cancer-therapy","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2026\/07\/acid-resistant-nanocage-shows-promise-for-targeted-gastric-cancer-therapy","title":{"rendered":"Acid-resistant nanocage shows promise for targeted gastric cancer therapy"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/acid-resistant-nanocage-shows-promise-for-targeted-gastric-cancer-therapy2.jpg\"><\/a><\/p>\n<p>Researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), have developed a swallowable nanoscale delivery platform designed to transport therapeutic enzymes through the stomach\u2019s acidic environment and activate a cancer-killing reaction at tumor sites. Early preclinical findings suggest that the approach may offer a new strategy for treating gastric cancer more precisely while reducing damage to healthy tissue.<\/p>\n<p>The preclinical study, <a href=\"https:\/\/link.springer.com\/10.1186\/s12951-026-04065-2\" target=\"_blank\">published<\/a> in the <i>Journal of Nanobiotechnology<\/i>, was led by associate professor Chester Lee Drum, Department of Medicine and the Cardiovascular-Metabolic Disease Translational Research Program (TRP), NUS Medicine, together with co-first authors Dr. Muthu Kumaraswamy Shanmugam and Dr. Girish Vallerinteavide Mavelli, both senior research fellows at the Department of Medicine, NUS Medicine.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), have developed a swallowable nanoscale delivery platform designed to transport therapeutic enzymes through the stomach\u2019s acidic environment and activate a cancer-killing reaction at tumor sites. Early preclinical findings suggest that the approach may offer a new strategy for treating gastric [\u2026]<\/p>\n","protected":false},"author":630,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,4],"tags":[],"class_list":["post-241232","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-nanotechnology"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/241232","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/630"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=241232"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/241232\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=241232"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=241232"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=241232"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}